LoginSignup
Viatris logo

Viatris

Stock
Stock
ISIN: US92556V1061
Ticker: VTRS
US92556V1061
VTRS

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 18.03.2025

$0.163

CHART BY

Frequently asked questions

What is Viatris's market capitalization?

The market capitalization of Viatris is $14.28B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is the Earnings Per Share (EPS) for Viatris?

Viatris's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.739. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Viatris's stock?

Currently, 11 analysts cover Viatris's stock, with a consensus target price of $13.17. Analyst ratings provide insights into the stock's expected performance.

What is Viatris's revenue over the trailing twelve months?

Over the trailing twelve months, Viatris reported a revenue of $15.03B.

What is the EBITDA for Viatris?

Viatris's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $4.22B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Viatris?

Viatris has a free cash flow of $1.95B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Viatris have, and what sector and industry does it belong to?

Viatris employs approximately 38,000 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.

What is the free float of Viatris's shares?

The free float of Viatris is 1.16B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$14.28B
EPS (TTM) 
-$0.739
Free Float 
1.16B
Revenue (TTM) 
$15.03B
EBITDA (TTM) 
$4.22B
Free Cashflow (TTM) 
$1.95B

Pricing

1D span
$11.58$11.96
52W span
$9.925$13.61

Analyst Ratings

The price target is $13.17 and the stock is covered by 11 analysts.

Buy

1

Hold

8

Sell

2

Information

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Employees
38,000
Industries
Pharmaceuticals: Major
Sector
Health Care

Identifier

ISIN
US92556V1061
Primary Ticker
VTRS

Knockouts

Join the conversation
Sign upLogin